Outcome measures in pediatric polypharmacy research: a scoping review.

Golchin NegarHannah JohnsonPaul M BakakiNeal DawsonElia M Pestana KnightSharon B MeropolRujia LiuJames A FeinsteinShari D BolenLawrence C KleinmanAlexis Horace

Published in: Drugs & therapy perspectives : for rational drug selection and use (2019)

Most studies of pediatric polypharmacy evaluate prevalence, prognosis, or adverse drug reaction-related out-comes, and underscore harms related to polypharmacy. Clinicians should carefully weigh benefits and harms when introducing medications to treatment regimens.

Keyphrases

adverse drug
electronic health record
drug induced
emergency department
risk factors
smoking cessation
combination therapy